TY - JOUR T1 - New horizons in multimodality molecular imaging and novel radiotracers JF - Clinical Medicine JO - Clin Med SP - 444 LP - 448 DO - 10.7861/clinmedicine.17-5-444 VL - 17 IS - 5 AU - Sally Barrington AU - Philip Blower AU - Gary Cook Y1 - 2017/10/01 UR - http://www.rcpjournals.org/content/17/5/444.abstract N2 - Positron emission tomography (PET)/computerised tomography is now established in clinical practice for oncologic and non-oncological applications. Improvement and development of scanner hardware has allowed faster acquisitions and wider application. PET/magnetic resonance imaging offers potential improvements in diagnostic accuracy and patient acceptability but clinical applications are still being developed. A range of new radiotracers and non-radioactive contrast agents is likely to lead to a growth in hybrid molecular imaging applications that will allow better characterisation of disease processes. ER -